FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

386977009: daclizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461155012 Daclizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481091011 Daclizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
620131000241114 daclizumab (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
803581000172119 daclizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclizumab (substance) est un(e) (attribut) Immunosuppressant (substance) true Inferred relationship Some
Daclizumab (substance) est un(e) (attribut) Monoclonal antibody (substance) true Inferred relationship Some
Daclizumab (substance) est un(e) (attribut) Monoclonal antibody agent (substance) false Inferred relationship Some
Daclizumab (substance) est un(e) (attribut) anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
Daclizumab (substance) Has disposition (attribute) Murine-human monoclonal immunoglobulin G antibody (disposition) false Inferred relationship Some
Daclizumab (substance) Has disposition (attribute) Immunomodulator (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only daclizumab (medicinal product) a pour principe actif (attribut) True Daclizumab (substance) Inferred relationship Some 1
Daclizumab only product in parenteral dose form a pour principe actif (attribut) True Daclizumab (substance) Inferred relationship Some 1
Product containing daclizumab in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Daclizumab (substance) Inferred relationship Some 1
Product containing daclizumab (medicinal product) a pour principe actif (attribut) True Daclizumab (substance) Inferred relationship Some 1
Daclizumab 25mg/5 mL solution (product) a pour principe actif (attribut) False Daclizumab (substance) Inferred relationship Some
Daclizumab 25mg/5mL infusion concentrate (product) a pour principe actif (attribut) False Daclizumab (substance) Inferred relationship Some
Daclizumab 25mg/5mL conventional release solution for injection (product) a pour principe actif (attribut) False Daclizumab (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start